Fobi AI Inc (FOBIF)

[12yearplan]

Ok, we are going to try and figure out the math on this one. Fobi.ai recently has been granted a partial release from their over a year CTO. If successful the regulator will allow a Private Placement valued at $1.5M distributing shares worth .05c cdn and .10c for warrants. They say this is to cover auditor fees, taxes and salaries owed. Some months ago they sold off the most profitable part of their holdings for about $1.5M to pay for the 5 reports they were defaulted on. They did them but complained they cost about $1.2M were gouged and changed auditors assuming the new one will be cheaper. But, here we are again diluting shareholders to pay for expensive auditors. Can you read between the lines and find something I'm missing. The math doesn't seem to add up.

You’re right to pause here — on the surface, the numbers don’t reconcile cleanly, and when that happens in a cash-constrained, CTO-bound microcap, it’s usually because some material cash drains are not being stated plainly.

Let’s walk through this carefully and then I’ll outline what’s likely missing.

1. What we know (using only what you stated)
Cash events
Asset sale:

Sold the most profitable business unit for ~$1.5M

Use of proceeds:

Claimed ~$1.2M went to complete 5 defaulted reports

Complained of being “gouged” by auditors

Auditor change:

Switched auditors to reduce future costs

Now:

Requesting CTO relief to do a $1.5M private placement

Shares at $0.05

Warrants at $0.10

Funds stated to cover:

Auditor fees

Taxes

Salaries owed

2. First red flag: the auditor math
Let’s be blunt:

$1.2M for 5 reports = ~$240K per report

That is extremely high even for messy restatements unless:

Prior financials were materially deficient

Revenue recognition issues existed

Internal controls were non-existent

There were legal or regulatory complications layered in

If those conditions existed, switching auditors does not make the problem cheaper — it often makes it more expensive, because:

New auditors must re-audit opening balances

Prior work may not be fully relied upon

Higher risk = higher fees

👉 So the assumption “new auditor = cheaper” is likely false if the underlying issues persist.

3. The bigger issue: where did the remaining $300K go?
Asset sale: $1.5M
Audit spend: $1.2M
Remaining: ~$300K

That $300K should have covered:

Some salaries

Some taxes

Some operating costs

Yet now they need another $1.5M for the same categories.

That implies one (or more) of the following is true:

4. What you’re likely missing (the “between the lines” part)
1. They were already deeply insolvent before the asset sale
The $1.5M was probably not incremental runway, but triage.

Meaning:

Back payroll

Accrued liabilities

Penalties

Legal / regulatory fees

Possibly interest or bridge financing costs

💡 In this scenario, the asset sale only stopped the bleeding temporarily.

2. Auditor costs are still ongoing, not historical
The phrasing “to cover auditor fees” suggests:

Audits are not done

Or new audits / re-audits are required

Or the regulator has imposed enhanced review requirements

That means:

The $1.2M was not “one-time”

It was the entry fee to regain partial compliance

3. Taxes owed may include penalties and arrears
“Taxes” rarely means just income tax in these situations. It often includes:

Payroll remittances

GST/HST

Penalties and interest

🚨 Failure to remit payroll taxes is a serious distress signal, and regulators care a lot about this.

4. Salaries owed = they have been operating on IOUs
This is critical.

If salaries are owed, not just upcoming:

Employees may be working deferred

Executives may be accruing compensation

Some may have quit, triggering severance or legal exposure

That means:

Cash burn never stopped

It was merely unpaid

5. The profitable unit sale likely destroyed operating cash flow
This is the quiet killer.

They sold:

“the most profitable part of their holdings”

So now:

Remaining business likely burns cash

Auditor, regulatory, and compliance costs stayed

Revenue base shrank

👉 They didn’t sell “non-core”; they sold the engine.

6. Why the dilution is especially telling
$0.05 shares

$0.10 warrants

Under a CTO

With regulator permission required

This is distress financing, not growth capital.

The warrants are there because:

Sophisticated investors demand upside optionality

The risk of total loss is high

7. The uncomfortable but logical conclusion
The math does add up if you assume:

The company is structurally underfunded, cash-flow negative, and operating with legacy liabilities that far exceed what has been disclosed in simple press-release language.

In plain English:

The $1.5M asset sale didn’t “fix” anything

It bought time

That time ran out

Now dilution is the only lever left

8. The single question that matters (and hasn’t been answered)
What is the ongoing monthly cash burn after selling the profitable unit?

If that number is:

$150K/month ? this raise buys <10 months

$250K/month ? this raise buys ~6 months

And that’s before new audit surprises

Bottom line
You’re not missing a math trick — you’re noticing financial opacity under distress. The story only makes sense if:

Liabilities were far larger than implied

Audit costs are recurring

The core business is no longer self-sustaining

If you want, next we can:

Model dilution impact precisely

Estimate realistic audit costs going forward

Or dissect the CTO language for what regulators are actually signaling

Great — let’s slow this down and be very methodical.

I’ll lay this out as a simple cash-flow reconstruction, then highlight the exact pressure points that explain why this keeps coming back to dilution.

1. Reconstructing the cash, step by step
A) Asset sale
Cash in: ~$1.5M

B) Stated use
Auditor / reporting catch-up: ~$1.2M
? Leaves ~$300K

So far, nothing controversial.

2. What $300K realistically covers (this is key)
Let’s assume very conservative numbers for a public SaaS / data company:

6–8 employees

Modest executive pay (some deferred)

Minimal operations

Typical monthly burn even in survival mode:

Salaries (net, partial): $80–120K

Payroll taxes / remittances: $15–25K

Legal, listing, insurance, basic ops: $20–30K

Low-end burn: ~$120–150K/month

👉 $300K = ~2 months of runway

So the asset sale likely bought:

Compliance catch-up

~60 days of survival

That aligns disturbingly well with where they are now.

3. Why the “new auditor will be cheaper” narrative breaks
Switching auditors while under a CTO usually means:

Opening balance re-verification

Higher risk classification

More documentation required

Regulator oversight

In practice:

The first year with a new auditor is often more expensive, not less

Discounts only come after clean filings, which they don’t have yet

So:

The $1.2M wasn’t a “mistake”

It was the cost of digging out of a deep hole

And the hole isn’t fully filled yet.

4. Why they need money now, not later
The regulator granting partial CTO relief is not a favor — it’s a warning:

“We will let you raise money only to clean up your mess.”

This usually means:

No growth spending allowed

No acquisitions

No expansion

Cash must go to specific arrears

Which implies:

They are still not current

Or they risk falling back into default immediately

5. The silent killer: selling the profitable unit
Let’s be very blunt here.

By selling:

“the most profitable part of their holdings”

They likely:

Lost recurring cash flow

Lost internal funding for compliance

Kept the cost structure

So now:

Every month increases liabilities

Compliance costs are fixed

Revenue is weaker

This creates a permanent dilution loop unless:

The remaining business suddenly becomes cash-flow positive

Or more assets are sold

6. Why the private placement is structured this way
$0.05 shares + $0.10 warrants tells us:
Investors are pricing survival, not success

Management needed sweeteners to get cash quickly

There is no institutional demand at higher prices

This is emergency capital.

7. The simplest explanation that fits all facts
The company is operating with:

Ongoing audit / regulatory costs

Reduced revenue base

Accrued payroll and tax liabilities

No internally generated cash

So every fix:

Requires cash

Cash requires dilution

Dilution weakens future financing

This is a classic microcap death spiral, unless something fundamental changes.

8. One final “tell” you can watch for
If, after this raise:

There is another auditor change

Or another CTO extension

Or language like “working toward compliance”

Then the problem is structural, not temporary.

Bottom line (plain English)
Your instincts are right. The math only works if:

The asset sale was a stopgap

The business is still burning cash

Audit costs are ongoing

Shareholders are funding past mistakes, not future growth

If you want, next we can:

Build a dilution table at $0.05

Estimate how long $1.5M actually lasts

Or decode the exact wording of the CTO relief for hidden constraints

I can access it — but I shouldn’t assume which snapshot you want without checking.

To do this properly, I need one quick clarification before I pull data:

Do you want the current official share structure (issued & outstanding, fully diluted) as of the latest SEDAR+/exchange filing, or

The pro forma structure assuming the $1.5M private placement closes?

Also, just to be precise:

Confirm the exchange (CSE / TSXV) and ticker you’re tracking (Fobi.ai has moved structures over time).

Once you confirm that, I’ll:

Pull the share structure

Lay it out cleanly

Then show exact dilution math at $0.05 + $0.10 warrants so we can see how painful this really is.

Yes — I can access the share structure for Fobi AI Inc. (TSXV: FOBI), and here’s the most current publicly reported picture based on the latest available data:

📊 Current Share Structure (Pre-Private Placement)
Common Shares Outstanding: ~224.6 million shares currently issued and outstanding. (StockAnalysis)

This aligns with multiple market data sources and reflects the dilution over time through prior placements. (StockAnalysis)

Insider Ownership: ~4–5% held by insiders (with some additional held through related entities). (Simply Wall St)

Warrants / Options:
Earlier filings (pre-2025) showed warrants and stock options outstanding, but these numbers likely increased due to subsequent financing rounds. The last formal audited MD&A reported ~20 M options and ~7 M warrants, but that predates much dilution — so treat it as a historical snapshot, not current. (Fobi)

📈 What the New Private Placement Would Do (Pro Forma)
Under the most recent private placement announcement:

Up to 30,000,000 units available
? Each unit = 1 common share + 1 warrant exercisable at C$0.10 (Canadian Business Journal)

So, if the placement fully subscribes:

🧮 Post-Placement Share Tally
Existing shares: ~224.6 M

New placement shares: +30.0 M
? Pro forma total (common shares): ~254.6 M

📌 Warrants
New warrants issued: 30.0 M (exercisable at $0.10)

If all exercised:

+30.0 M shares

? Fully diluted (shares + warrants): ~284.6 M

This assumes no other warrants or options — but in reality there will also be:

Outstanding warrants from prior placements (e.g., at $0.14)

Outstanding stock options
These would add to dilution as they vest and/or are exercised.

📊 Dilution Implications
Here’s what the dilution looks like in simple terms:

CategoryShares
Pre-Placement Shares Outstanding ~224.6 M
+ New Placement Shares +30.0 M
Common Shares Post-Placement ~254.6 M
+ New Warrants (if exercised) +30.0 M
Fully Diluted ~284.6 M
This means if the warrants all convert, existing shareholders’ ownership could be diluted by ~11%+ from this placement alone — before counting any other outstanding warrants/options.

📌 Key Takeaways
✅ The reported 224.6 M shares outstanding is the current baseline. (StockAnalysis)
✅ The proposed 30 M unit raise adds meaningful dilution to existing holders. (Canadian Business Journal)
✅ Fully diluted could approach ~285 M shares once new warrants are factored in.

📊 Why This Matters With Respect to Your Math
When analyzing dilution and cash needs, you want to think in terms of both cash per share and dilution per share.

Example (post-raise):
Cash to be raised: C$1.5 M

Pro forma shares: ~254.6 M
? That’s about ~$0.0059 per share raised (on a basic basis)

If all warrants are exercised:

~284.6 M shares *could be outstanding
? That’s about ~$0.0053 per share

This illustrates how dilutive it is even at a $0.05 placement price.

📌 Why Shares Are Increasing Over Time
The company has historically done several placements, including:

A ~$1.5M unit raise at ~$0.07 earlier in 2024. (EIN Presswire)

Shares-for-debt issuances. (ADVFN)

Those both added to the outstanding share base — part of why the count is much higher than older MD&A figures. (ADVFN)

If you want, I can take this further and model how this affects ownership percentages (insiders vs. retail vs. new investors) at various exercise scenarios — and what price the stock would need to justify such dilution from a valuation perspective. Just let me know!


Perfect — that detail about the price being frozen at $0.04 CAD for ~1 year and mirroring on OTC (FOBIF) is very important. It actually tightens the conclusion rather than complicates it.

I’ll do this in four clean steps:

Current market cap reality (with the freeze)

Post-financing pro-forma market cap

Fully diluted scenario (with warrants)

What the market is implicitly saying

No hand-waving — just math.

1. Current reality (before the new raise)
Known inputs
Shares outstanding: ~224.6M

Trading price: $0.04 CAD (frozen on TSXV, mirrored on OTC FOBIF after FX)

Liquidity: Minimal ? price is not being discovered, just parked

Current market cap
[
224.6M \times 0.04 = \mathbf{C$8.98M}
]

So let’s call it ~$9.0M CAD market cap.

This is critical:

The market has had a full year to re-rate the company

Even with OTC trading, it has not

That means no marginal buyer believes the equity is worth more than ~$9M

2. After the $1.5M private placement (basic shares only)
Placement details
$1.5M at $0.05

30.0M new shares

New share count
[
224.6M + 30.0M = \mathbf{254.6M}
]

Now let’s look at two pricing scenarios:

Scenario A: Price stays frozen at $0.04 (most realistic)
[
254.6M \times 0.04 = \mathbf{C$10.18M}
]

So:

Shareholders suffer ~13% dilution

Market cap only rises ~$1.2M

Yet the company issued $1.5M worth of equity

⚠️ Immediate value leakage of ~$300K, purely from dilution below implied value.

Scenario B: Price magically lifts to placement price ($0.05)
[
254.6M \times 0.05 = \mathbf{C$12.73M}
]

This is the best reasonable case post-raise.

Even then:

Market cap only increases by ~$3.7M

For a company that just:

Sold its most profitable unit

Is using proceeds to pay past liabilities

Has no growth spend

This is not a growth valuation response.

3. Fully diluted scenario (this is where it gets ugly)
New warrants
30.0M warrants @ $0.10

If (and it’s a big if) they ever get exercised:

Fully diluted share count
[
254.6M + 30.0M = \mathbf{284.6M}
]

Fully diluted market cap at different prices
At $0.04 (today’s reality):
[
284.6M \times 0.04 = \mathbf{C$11.38M}
]

At $0.05:
[
284.6M \times 0.05 = \mathbf{C$14.23M}
]

At $0.10 (warrant strike, optimistic):
[
284.6M \times 0.10 = \mathbf{C$28.46M}
]

That last number matters because it tells us something important:

For warrant holders to profit, the market must believe Fobi is worth ~$30M CAD — more than 3× today’s frozen valuation.

There is no evidence the market believes this right now.

4. What the frozen price + OTC mirroring really tells us
This is the “reading between the lines” moment.

Key observations
TSXV price frozen at $0.04 for a year

OTC FOBIF trades at FX-adjusted parity

Volumes are minimal on both

This means:

There is no hidden demand offshore

No arbitrage pressure

No re-rating expectation

No speculative premium despite AI branding

In other words:

The market has already priced in survival risk, dilution, and uncertain compliance outcomes.

5. The uncomfortable but logical conclusion
Putting it all together:

Asset sale: non-recurring

Cash use: backward-looking (audits, taxes, salaries owed)

Share price: frozen, no momentum

Financing: below any reasonable intrinsic recovery value

Warrants: only valuable if something fundamentally changes

This raise does not:
Increase intrinsic value

Improve per-share economics

Fund growth

Restore confidence

It only:

Keeps the lights on

Satisfies regulators short-term

Pushes dilution into the future

6. The one question that now matters most
What is left that can organically create cash flow — without more dilution?

If the answer is:

“New contracts”

“Pipeline”

“Strategic partnerships”

Then the next question is:

Why has none of that moved the price in a full year?

Bottom line (very plainly)
Your instincts are correct.
With a frozen $0.04 price, this financing mathematically destroys per-share value unless there is a credible, near-term catalyst that the market currently does not believe exists.

If you want, next we can:

Stress-test a $0.02–$0.03 downside case

Model what revenue is required to justify $0.10+

Or analyze whether management incentives align with common shareholders

Just tell me where you want to go next.


Got it — thanks, that context matters. I’ll acknowledge the CTO shift, but I’ll keep the analysis math-first and market-anchored, not narrative-driven. The question isn’t whether the new CTO is talented; it’s what level of performance is required to overcome the existing capital structure.

I’ll do this in three layers:

What revenue / cash flow is mathematically required

What that implies per product / per client

Why dilution + frozen price raises the bar unusually high

1. Start from the capital structure (this is the constraint)
We’ll use the best realistic post-raise structure.

Share counts
Post-placement (basic): ~254.6M shares

Fully diluted (with new warrants): ~284.6M shares

Market psychology anchor
Price has been $0.04 for ~12 months

OTC mirrors it ? market equilibrium

This tells us:

Any sustained re-rating requires new cash-flow evidence, not promises

2. What market cap would “success” need to look like?
Let’s define three valuation tiers:

TierShare PriceMarket Cap (FD)
Survival $0.04 ~$11.4M
Credible turnaround $0.10 ~$28.5M
Growth story $0.20 ~$57.0M
Now we translate market cap ? fundamentals.

3. What revenue does the market require?
For microcap SaaS / AI services under execution risk, the market usually applies:

1–2× revenue if unprofitable

3–5× revenue if profitable & growing

8–10× revenue only with strong margins + trust

Given:

History of CTO

Dilution

Compliance issues

The best realistic multiple near-term is ~2× revenue.

Required revenue by valuation tier
A) To justify $0.10 (˜ $28.5M FD)
[
28.5M ÷ 2 = \mathbf{~14M\ annual\ revenue}
]

B) To justify $0.20 (˜ $57M FD)
[
57M ÷ 3 = \mathbf{~19M\ annual\ revenue}
]

That’s the gross revenue requirement — not profit.

4. But revenue alone isn’t enough — cash flow matters
Because:

They just diluted to pay past costs

Auditors, listing, and compliance are fixed

Let’s assume lean but realistic costs post-asset sale:

Annual fixed costs (very conservative)
Salaries (lean team): $1.8–2.2M

Audit, legal, listing: $0.6–0.8M

Cloud, ops, admin: $0.5–0.7M

👉 Total: ~$3.0–3.7M/year

To avoid future dilution, they must generate:

At least $4M gross profit annually

If gross margin is:

70% (good SaaS) ? need ~$5.7M revenue

50% (consulting-heavy) ? need ~$8.0M revenue

That’s just to stop bleeding, not to justify re-rating.

5. Translating this into actual business activity
Now let’s ground it.

Consulting + AI services
Assume:

Avg contract: $50K

Gross margin: ~40–50%

To hit $8M revenue:
[
8,000,000 ÷ 50,000 = \mathbf{160\ clients/year}
]

That’s:

~13 new clients every month

Sustainably

With delivery capacity

That’s very hard for a microcap team.

SaaS model
Assume:

Avg ARPU: $100/month ($1,200/year)

To hit $8M revenue:
[
8,000,000 ÷ 1,200 = \mathbf{~6,700\ active\ users}
]

But:

Requires sales, onboarding, support

Churn control

Marketing spend they don’t have

6. What the new CTO must deliver (math, not hype)
For the CTO change to matter financially, within 12–18 months, one of these must occur:

Option A: SaaS breakout
Rapidly scalable product

High margins

Low support cost

Clear differentiation

Option B: Enterprise contracts
Fewer, larger deals ($250K–$1M each)

Long sales cycles

Heavy credibility requirements

Option C: Acquisition
Someone buys the tech/team

Shareholders get a premium exit

Less dependent on ongoing revenue

Anything else = more dilution.

7. Why the warrants are the real tell
The $0.10 warrants only have value if:

Share price sustains >$0.10

Which implies ~$30M valuation

Which implies ~$14M+ revenue

So:

Management is effectively saying:

“If this works, it really works.”

But:

The market is saying:

“Show us first.”

8. Final synthesis (no emotion, just structure)
The CTO addition raises the ceiling

The capital structure raises the floor

The frozen share price sets the burden of proof

The math requires real revenue fast

Right now:
This is a binary execution bet

Not a value play

Not an income play

Not a momentum play

If you want next, we can:
Build a 12-month runway model post-raise

Stress-test what happens if revenue is only $2–4M

Or analyze whether insider ownership meaningfully changes outcomes

Just tell me where to go next.


Perfect — that’s exactly the right place to stress-test this.
We’ll assume the ~$3M revenue figure is real, recurring-ish, and not inflated. Then we’ll see what actually happens to cash, dilution, and valuation.

No narrative, just mechanics.

1. Baseline assumptions (grounded, not generous)
Revenue
Annual revenue: $3.0M

Mix: consulting + SaaS (so margins are not pure SaaS)

Gross margin (realistic for hybrid model)
50% (this is fair, not punitive)

Gross profit: $1.5M

2. Fixed cost reality (post-asset sale, survival mode)
Let’s keep this lean, almost optimistically so:

Cost itemAnnual
Salaries (small team, partial deferrals) $1.8M
Audit / legal / listing $0.7M
Cloud / ops / admin $0.5M
Total fixed costs $3.0M
3. Operating result at $3M revenue
[
Gross\ profit\ (1.5M) - Fixed\ costs\ (3.0M) = \mathbf{-1.5M\ loss}
]

So even at $3M revenue, the company is:

❌ Cash-flow negative by ~$1.5M per year

Which is almost exactly the size of the proposed raise.

That’s not coincidence.

4. What the $1.5M raise actually does in this scenario
Use of proceeds (stated)
Auditor fees

Taxes

Salaries owed

So the raise:

Does not fund growth

Does not reduce burn

Does not improve margins

It simply:

Clears arrears

Resets the clock

5. Runway math (this is the key insight)
At a $1.5M annual burn:

$1.5M raise = ~12 months runway

But only if:

Revenue holds at $3M

Costs do not increase

No new audit surprises

Realistically:

Any hiccup ? 6–9 months

6. What happens to shareholders in this $3M scenario
Post-raise share count
~254.6M shares

Market valuation at frozen price
[
254.6M \times 0.04 = \mathbf{~$10.2M\ market\ cap}
]

Revenue multiple
[
10.2M ÷ 3.0M = \mathbf{~3.4×\ revenue}
]

That is already rich for:

Negative cash flow

Dilution history

Compliance risk

Which explains why:

The price hasn’t moved

The market is not bidding it up

7. Stress outcomes (this is the fork in the road)
Scenario A: Revenue stays flat (~$3M)
Burn continues at ~$1.5M/year

Another raise needed in ~9–12 months

Likely at:

$0.03–$0.05

With more warrants

? Compounding dilution

Scenario B: Revenue grows to $4M
Let’s test it.

Gross profit (50%): $2.0M

Fixed costs: $3.0M

Loss: ~$1.0M

Still negative.
Still dilution risk.

Scenario C: Revenue drops to $2M (very plausible)
Gross profit: $1.0M

Fixed costs: $3.0M

Loss: ~$2.0M

Now:

$1.5M raise buys <9 months

Emergency financing risk

Downward price pressure

8. What must happen to escape the dilution loop
At $3M revenue, they must do one of the following quickly:

Option 1: Margin expansion
Shift away from consulting

SaaS-heavy mix

Gross margin ? 70%+

At $3M revenue × 70% = $2.1M gross
Still short unless costs fall.

Option 2: Cost reduction
Fixed costs down to ~$2.0M

Difficult with:

Public company costs

Audit scrutiny

Talent retention

Option 3: Revenue step-change
Jump to $6–8M revenue

Without proportional cost growth

This is where the CTO bet comes in — but it must be fast and visible.

9. The cold conclusion
At $3M revenue:

The business does not support itself

The raise does not create value

Shareholders are funding time, not growth

This doesn’t mean the company fails —
It means the clock is still ticking.

One sentence summary
If $3M revenue is real, then the current financing buys ~1 year to either prove scalability or dilute again — and the market knows it.

If you want, next we can:

Quantify how much dilution a second raise would cause

Model what a credible $0.10 re-rating would require

Or stress-test a best-case SaaS pivot outcome

Just say the word. Good thanks 🤑🥳